Status:

COMPLETED

Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease

Lead Sponsor:

Rennes University Hospital

Conditions:

Non-Alcoholic Fatty Liver Disease

Eligibility:

All Genders

18+ years

Brief Summary

The main objective is to compare the accuracy of transient elastography taking into account liver steatosis determined by MRI, to liver biopsy for the diagnosis of liver fibrosis ≥F2 in patient with N...

Detailed Description

No alcoholic fatty liver disease (NAFLD) is induced by an abnormal build up of fat in the liver. It can induce liver damage, namely fibrosis, which leads to cirrhosis and an increased risk of liver ca...

Eligibility Criteria

Inclusion

  • Patients older than 18 years old
  • For which a liver biopsy is indicated for NAFLD according to current guidelines
  • Presenting with at least one of the metabolic syndrome criteria:
  • BMI \> 25 kg/m² and/or Waist circumference ≥ à 94cm for men / ≥ à 80cm for women
  • Fasting glucose \> or = to 5,6 mmol/L or diabetes / or lowering glucose treatment
  • Blood pressure ≥ 130/85 mmHg / or treatment
  • Triglycerides ≥ than 1,7 mmol/L
  • HDL-C ≤ than 1 mmol/L (men), ≤ 1,3 mmol/L (women) /or lipid lowering treatment
  • Affiliated to medical care insurance
  • Having signed informed consent for participating in the study

Exclusion

  • Associated other chronic liver disease : infectious, auto immune, genetic
  • Alcohol consumption higher than 21 standard unit per week for men, or 14 standard unit for women;
  • Steatosis inducing treatment: steroids, amiodarone, methotrexate, tamoxifen
  • History of bariatric surgery
  • Contra indication to MRI (pace maker, metallic foreign body, claustrophobia)
  • Persons subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty.

Key Trial Info

Start Date :

December 7 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 7 2020

Estimated Enrollment :

270 Patients enrolled

Trial Details

Trial ID

NCT03245606

Start Date

December 7 2017

End Date

July 7 2020

Last Update

July 14 2020

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

CHU d'Angers

Angers, France, 49933

2

CHU de Bordeaux

Bordeaux, France, 33604

3

CHD Vendée

La Roche-sur-Yon, France, 85925

4

Groupe Hospitalier Bretagne Sud

Lorient, France, 56100